Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
Linus Angenendt(Board of the Swiss Federal Institutes of Technology), Christoph Schliemann(University Hospital Münster), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux), Pau Montesinos(Instituto de Salud Carlos III), Martin Höglund(Uppsala University), Andrew H. Wei(The Royal Melbourne Hospital), Christian Thiede(University Hospital Carl Gustav Carus), Matthias Stelljes(University Hospital Münster), Michael Krämer(University Hospital Carl Gustav Carus), Jean‐Baptiste Micol(Université Paris-Saclay), Christine Terré(Hôpital André Mignot), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), Eva Barragán(Hospital Universitari i Politècnic La Fe), David Martínez‐Cuadrón(Instituto de Salud Carlos III), Rita Exeler(University of Münster), Jörge E. Cortes(Augusta University Health), Gerhard Ehninger(University Hospital Carl Gustav Carus), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Tapan M. Kadia(The University of Texas MD Anderson Cancer Center), Utz Krug(Klinikum Leverkusen), Wolfgang E. Berdel(University Hospital Münster), Ing Soo Tiong(The University of Melbourne), Christoph Röllig(University Hospital Carl Gustav Carus), Gunnar Juliusson(Lund University), Zdeněk Ráčil(Masaryk University), Sarah Bertoli(Memorial Sloan Kettering Cancer Center), Georg Lenz(Charité - Universitätsmedizin Berlin), Friedrich Stölzel(German Cancer Research Center), Lisa Wagenführ(University Hospital Carl Gustav Carus), Elihu H. Estey(University of Washington), Meaghan Wall(St Vincent's Hospital Melbourne), Jan Novák(Institute of Haematology and Blood Transfusion), Sören Lehmann(Uppsala University), Carmen Botella(Hospital General Universitario de Alicante Doctor Balmis), Hubert Serve(Goethe University Frankfurt), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Pilar Martı́nez(Research Institute Hospital 12 de Octubre), Vladimir Lazarević(Skåne University Hospital), Pavel Žák(University Hospital Hradec Králové), Jan-Henrik Mikesch(University Hospital Münster), Carole Shaw(University of Washington), Raimundo García(Hospital General Universitari de Castelló), Hervé Dombret(University of London Institute in Paris), Pierre-Yves Dumas(Centre Hospitalier Universitaire de Bordeaux), Farhad Ravandi(The University of Texas MD Anderson Cancer Center)
Cited by 116
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k